Scientech Research LLC Purchases 7,267 Shares of Envista Holdings Co. (NYSE:NVST)

Scientech Research LLC increased its position in shares of Envista Holdings Co. (NYSE:NVST) by 28.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,611 shares of the company’s stock after purchasing an additional 7,267 shares during the period. Scientech Research LLC’s holdings in Envista were worth $542,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. PNC Financial Services Group Inc. boosted its stake in Envista by 271.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 24,123 shares of the company’s stock valued at $580,000 after buying an additional 17,624 shares in the last quarter. TFO Wealth Partners LLC boosted its stake in Envista by 64,777.8% in the 4th quarter. TFO Wealth Partners LLC now owns 5,839 shares of the company’s stock valued at $140,000 after buying an additional 5,830 shares in the last quarter. Alberta Investment Management Corp boosted its stake in Envista by 41.7% in the 4th quarter. Alberta Investment Management Corp now owns 294,417 shares of the company’s stock valued at $7,084,000 after buying an additional 86,700 shares in the last quarter. KBC Group NV boosted its stake in Envista by 37.9% in the 4th quarter. KBC Group NV now owns 13,797 shares of the company’s stock valued at $332,000 after buying an additional 3,792 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in Envista by 20.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 905,317 shares of the company’s stock valued at $21,782,000 after buying an additional 155,192 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on NVST. Piper Sandler decreased their price target on Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 30th. Bank of America reduced their price objective on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. JPMorgan Chase & Co. cut Envista from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. Stifel Nicolaus decreased their target price on Envista from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, July 30th. Finally, Evercore ISI increased their target price on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Three analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $19.59.

Envista Price Performance

Envista stock opened at $19.76 on Friday. Envista Holdings Co. has a 12-month low of $15.15 and a 12-month high of $28.55. The business’s 50-day simple moving average is $17.67 and its 200 day simple moving average is $18.41. The company has a quick ratio of 1.90, a current ratio of 2.22 and a debt-to-equity ratio of 0.47. The stock has a market cap of $3.40 billion, a price-to-earnings ratio of -27.44 and a beta of 1.31.

Envista (NYSE:NVST) last released its earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.27 by ($0.16). Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The company had revenue of $633.10 million during the quarter, compared to analyst estimates of $646.88 million. During the same period in the previous year, the company posted $0.43 EPS. The company’s quarterly revenue was down 4.4% compared to the same quarter last year. As a group, research analysts anticipate that Envista Holdings Co. will post 0.69 earnings per share for the current year.

Insider Transactions at Envista

In other Envista news, CFO Eric D. Hammes purchased 24,532 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were bought at an average price of $16.33 per share, with a total value of $400,607.56. Following the completion of the transaction, the chief financial officer now directly owns 24,532 shares in the company, valued at approximately $400,607.56. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by insiders.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.